Bernward A. Schölkens

Author

Also Known As

B A Schölkens, B. A Scholkens, B. A. Scholkens, B. A. Schölkens, B. Scholkens, B. Schölkens, B.A. SCHÖLKENS, B.A. Schölkens, Bernward A Schölkens, Bernward A. Scholkens

174

Publications

9.5K

Citations

H-Index

Concepts

All Affiliations

Klinikum Frankfurt Höchst Gesundes Kinzigtal (Germany)Heidelberg University

About

Bernward A. Schölkens is an author at Klinikum Frankfurt Höchst specializing in medicine, physiology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	60	3.8K
2	Health Sciences	6	6	248
3	Public Health	2	2	52
4	Natural Sciences	1	1	30
5	Social Sciences	1	1	29

Bernward A. Schölkens

Publications

7.9K

Citations

H-Index

Page 1

	Year	Citations
Hoe 140 a new potent and long acting bradykinin‐antagonist:<i>in vivo</i>studies Klaus Wirth, Franz J. Hock, Udo Albus, British Journal of Pharmacology	1991	835
Hoe 140 a new potent and long acting bradykinin‐antagonist:<i>in vitro</i>studies Franz J. Hock, Klaus Wirth, Udo Albus, British Journal of Pharmacology	1991	613
Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion W. Scholz, Udo Albus, Laurent Counillon, Cardiovascular Research	1995	417
Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin. Gabriele Wiemer, Bernward A. Schölkens, R. H. A. Becker, Hypertension Nitric OxideImmunologyCardiovascular PharmacologyCyclic Gmp AccumulationOxidative Stress	1991	353
Converting Enzyme Inhibition Specifically Prevents the Development and Induces Regression of Cardiac Hypertrophy in Rats Wolfgang Linz, Bernward A. Schölkens, Detlev Ganten Clinical and Experimental Hypertension Part A Theory and Practice	1989	336
Endothelial Dysfunction Coincides With an Enhanced Nitric Oxide Synthase Expression and Superoxide Anion Production Anne Bouloumié, Johann Bauersachs, Wolfgang Linz, Hypertension	1997	300
A specific B<sub>2</sub>‐bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril Wolfgang Linz, Bernward A. Schölkens British Journal of Pharmacology	1992	235
Beneficial Effects of the Converting Enzyme Inhibitor, Ramipril, in Ischemic Rat Hearts Wolfgang Linz, Bernward A. Schölkens, Yifan Han Journal of Cardiovascular Pharmacology HypertensionHeart FailureVentricular FibrillationCardiovascular DiseaseBeneficial Effects	1986	207
Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist Piero A. Martorana, Birgit Kettenbach, Gerhard Breipohl, European Journal of Pharmacology ThrombosisHypertensionHeart FailureCardiovascular DiseaseMedicine	1990	202
Hoe 694, a new Na+/H<sup>+</sup> exchange inhibitor and its effects in cardiac ischaemia Wolfgang Scholz, Udo Albus, Hans‐Jochen Lang, British Journal of Pharmacology Cardiac IschaemiaCardiac MuscleHeart FailureCardiovascular PharmacologyPharmacotherapy	1993	183

Page 1